Literature DB >> 12526157

Construction of multiply disabled herpes simplex viral vectors for gene delivery to the nervous system.

Caroline E Lilley1, Robert S Coffin.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12526157     DOI: 10.1385/1-59259-304-6:33

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  1 in total

1.  Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.

Authors:  Suzanne Thomas; Linta Kuncheria; Victoria Roulstone; Joan N Kyula; David Mansfield; Praveen K Bommareddy; Henry Smith; Howard L Kaufman; Kevin J Harrington; Robert S Coffin
Journal:  J Immunother Cancer       Date:  2019-08-10       Impact factor: 13.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.